Shares in Venture Life (LON:VLG) are currently trading close to a 52 week high, with the share price up by around 9.68% - to 102 - over the past week. On a one-month basis, the Venture Life share price has risen by 2.00%. For investors...
VLG — Venture Life Share Price
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro CapNeutral
- £42.38m
- £49.87m
- £32.76m
Momentum
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 8.19 | ||
| PEG Ratio (f) | 0.32 | ||
| EPS Growth (f) | 34.32% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.58 | ||
| Price to Tang. Book | 5.24 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 1.29 | ||
| EV to EBITDA | 9.83 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 1.47% | ||
| Return on Equity | 3.31% | ||
| Operating Margin | 4.18% | ||
Financial Summary
| Year End 31st Dec | Unit | 2017 | 2018 | 2019 | 2020 | 2021 | 2022E | 2023E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | £m | 16.05 | 18.77 | 20.21 | 30.08 | 32.76 | 40.91 | 45.63 | 18.07% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | +109.71 | +155.32 | -20.19 | +56.19 | +20.4 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Health Trend(F-Score)
12345678910
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Latest News & Insights for VLG
It's a good time to be a shareholder in Venture Life (LON:VLG): as the share approaches its 52-week high, holders may be wondering whether to sell and take the profit, or buy more and ride the uptrend. Shares in Venture Life are curren...
Shares in Venture Life (LON:VLG) are currently trading close to a 52 week high, with the share price up by around 17.0% - to 102.5 - over the past week. On a one-month basis, the Venture Life share price has risen by 10.2%. For investo...
Shares in Venture Life (LON:VLG) are currently trading close to a 52 week high, with the share price up by around 4.92% - to 96.72 - over the past week. On a one-month basis, the Venture Life share price has risen by 20.0%. For investo...
The good news for any holders of Venture Life (LON:VLG) is that the price is currently trading close to a 52 week high, with the share price up by around 10.7% to 86.551 over the past week. For investors holding the stock (or consider...
Profile Summary
Venture Life Group plc is a United Kingdom-based consumer self-care company. The Company is focused on developing, manufacturing and commercializing products for the global self-care market. The Company's segments include Brands, which includes sales of healthcare and skin care products under distribution agreements and direct to United Kingdom retailers, and Development and Manufacturing. Through its two Development and Manufacturing operations in Italy and Sweden, the Company also provides development and manufacturing services to companies in the medical devices and cosmetic sectors. Its product portfolio includes the UltraDEX and Dentyl oral care product ranges, the Balance Active range in the area of women's intimate healthcare, the Lift and Glucogel product ranges for hypoglycaemia, Gelclair and Pomi-T for oncology support, products for fungal infections and proctology, and dermo-cosmetics for addressing the signs of ageing.
Directors
- Lynn Drummond NEC (61)
- Jerry Randall CEO
- Daniel Wells CFO (34)
- Giuseppe Gioffre CTR
- Gianluca Braguti EDR
- Sharon Daly EDR
- Peter Bream NED (54)
- Carl Dempsey NED
- Last Annual
- December 31st, 2021
- Last Interim
- December 31st, 2021
- Incorporated
- December 12th, 2005
- Public Since
- March 28th, 2014
- No. of Employees
- 145
- Sector
- Pharmaceuticals
- Industry
- Healthcare
- Exchange
- London Stock Exchange
- Shares in Issue
- 126,498,197
- Address
- Unit 12, The Courtyard, Eastern Road, BRACKNELL, RG12 2XB
- Web
- https://www.venture-life.com/
- Phone
- +44 1344578004
- Contact
- Daniel Wells
- Auditors
- Grant Thornton UK LLP
Latest News for VLG
Upcoming Events for VLG
Half Year 2022 Venture Life Group PLC Earnings Release
Similar to VLG
Abcam
London Stock Exchange
Alliance Pharma
London Stock Exchange
Animalcare
London Stock Exchange
AstraZeneca
London Stock Exchange
Benchmark Holdings
London Stock Exchange
FAQ
What is the Venture Life share price?
As of Today at 07:24 UTC, shares in Venture Life are trading at 33.50p. This share price information is delayed by 15 minutes.
How has the Venture Life share price performed this year?
Shares in Venture Life last closed at 33.50p and the price had moved by -63.19% over the past 365 days. In terms of relative price strength the Venture Life share price has underperformed the FTSE All Share Index by -62.01% over the past year.
What are the analyst and broker recommendations for Venture Life?
The overall consensus recommendation for Venture Life is Buy. You can view the full broker recommendation list by unlocking its StockReport.
What is the Venture Life dividend yield?
Venture Life does not currently pay a dividend.
Does Venture Life pay a dividend?
Venture Life does not currently pay a dividend.
When does Venture Life next pay dividends?
Venture Life does not currently pay a dividend.
How do I buy Venture Life shares?
To buy shares in Venture Life you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Venture Life?
As of the previous close price of 33.50p, shares in Venture Life had a market capitalisation of £42.38m.
Where are Venture Life shares listed?
Here are the trading details for Venture Life:
- Country of listing: United Kingdom
- Exchange: LSE
- Ticker Symbol: VLG
What kind of share is Venture Life?
Based on an overall assessment of its quality, value and momentum Venture Life is currently classified as a Neutral. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Venture Life share price forecast for 2022?
The analyst consensus target price for shares in Venture Life is 65.00p. That is 94.03% above the last closing price of 33.50p.
Analysts covering Venture Life currently have a consensus Earnings Per Share (EPS) forecast of £0.04 for the next financial year.
What is the trend in the Venture Life share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Venture Life. Over the past six months, its share price has outperformed the FTSE All Share Index by +21.19%.
As of the last closing price of 33.50p, shares in Venture Life were trading -20.35% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Venture Life PE Ratio?
The Venture Life PE ratio based on its reported earnings over the past 12 months is 8.19. The shares last closed at 33.50p.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Venture Life?
Venture Life's management team is headed by:
- Lynn Drummond - NEC
- Jerry Randall - CEO
- Daniel Wells - CFO
- Giuseppe Gioffre - CTR
- Gianluca Braguti - EDR
- Sharon Daly - EDR
- Peter Bream - NED
- Carl Dempsey - NED